The role of cardiac implantable electronic device (CIED)-related tricuspid regurgitation (TR)
is increasingly recognized as an independent clinical entity. Hence, interventional TR …

Severe tricuspid regurgitation (TR) worsens heart failure and is associated with impaired
survival. In daily clinical practice, patients are referred late, and tricuspid valve interventions …

Background Population-level data are limited regarding contemporary practice and
outcomes of isolated tricuspid operations. We evaluated this using The Society of Thoracic …

Background The development of transcatheter tricuspid edge-to-edge repair for tricuspid
regurgitation is a therapeutic milestone but a specific periprocedural risk assessment tool is …

Background Transcatheter tricuspid valve intervention (TTVI) has been increasingly adopted
in recent years for the treatment of patients with tricuspid regurgitation (TR). However, no …

OBJECTIVES Tricuspid regurgitation (TR) in patients who had heart transplants is
associated with poor outcome. The increased risk for surgical and postoperative …

OBJECTIVES To assess the incremental prognostic value of right ventricular free wall
longitudinal strain over conventional risk scores in predicting the peri-operative mortality in …

Objective Tricuspid valve surgery historically has been perceived as having elevated
operative risk, prompting the recent development of transcatheter therapies including …

Tricuspid regurgitation (TR) is a prevalent finding in echocardiography and in case of severe
disease is associated with impaired patient outcome. Clover repair offers a surgical solution …

Approximately 5% of elderly patients suffer from moderate or severe tricuspid valve
regurgitation, which is an independent predictor of high morbidity and mortality. Surgical …